We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates Q&A Guidance on Generic Drug Development During COVID-19 Pandemic
FDA Updates Q&A Guidance on Generic Drug Development During COVID-19 Pandemic
The FDA has revised its guidance on generic drug development and application submission during the COVID-19 public health emergency, providing additional information and clarification of existing policies but no policy changes.